Novartis B2 Ltd.
Novartis B2 Ltd. — US company (icij:icijol-80005338). 2 holdings. Cited to 1 registry.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
None in current sources.
- Novartis B2 Ltd.
- Novartis B3 Ltd.· shareholder of
- CBT Bermuda Holdings Ltd.· shareholder of
Nothing further is withheld here. The ownership and control links above are everything we have resolved for Novartis B2 Ltd. — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.
Coverage of Novartis B2 Ltd. is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.
Explore US coverage4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
Nothing further on Novartis B2 Ltd. is behind a paywall — everything we hold on this subject is already on this page.
People & control
2 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- CBT Bermuda Holdings Ltd.Also holds roles at 18 other companies
- Novartis B1 Ltd.shareholder of
- Jones - Michaeldirector of
- Jones - Michaelsecretary of
- Novartis B3 Ltd.Also holds roles at 35 other companies
- Novartis B1 Ltd.shareholder of
- CBT Bermuda Holdings Ltd.shareholder of
- Bartels - Ursula B.director of
2 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns Novartis B2 Ltd.?
- What is Novartis B2 Ltd.'s risk level?
- Where does Novartis B2 Ltd. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for Novartis B2 Ltd. — nothing is disclosed before that.